Drug profile · INN
artemether
COARTEM
artemether (COARTEM) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — artemether
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 2
- Programs
- 6
- Data quality
- 0.84
Quick answer
artemether (COARTEM) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Ferriprotoporphyrin IX inhibitor
Primary target: Ferriprotoporphyrin IX
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is artemether?
artemether (COARTEM) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for artemether?
COARTEM is a marketed brand name for artemether. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of artemether?
artemether has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.